News of Note—Astellas, Novavax and more

In this week's news of note, Astellas teamed up with ClearPath to work on a vaccine against S. aureus.

Here's some other vaccine news of note for the week:

> ClearPath and Astellas are teaming up to develop a Staphylococcus aureus vaccine. Release

> Novavax shares fell 22% as its updates this week in RSV and seasonal flu disappointed investors. Washington Business Journal article

Free Daily Newsletter

Like this story? Subscribe to FiercePharma!

Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on FiercePharma as their must-read source for the latest news, analysis and data on drugs and the companies that make them. Sign up today to get pharma news and updates delivered to your inbox and read on the go.

> A Stanford team found a new way to combat Zika that could aid in drug and vaccine development. FierceBiotechResearch article

> PharmaJet and Invectys teamed up for a phase 2 study of cancer vaccine INVAC-1 using PharmaJet's needle-free vaccine technology. Release